{"id":7629,"date":"2020-02-14T12:37:16","date_gmt":"2020-02-14T17:37:16","guid":{"rendered":"https:\/\/qa.vet.purdue.edu\/news\/?p=7629"},"modified":"2026-05-13T10:32:17","modified_gmt":"2026-05-13T14:32:17","slug":"bms-scholar-helps-lead-team-studying-worldwide-patented-innovations-available-for-gene-therapy-treatment","status":"publish","type":"post","link":"https:\/\/vet.purdue.edu\/news\/bms-scholar-helps-lead-team-studying-worldwide-patented-innovations-available-for-gene-therapy-treatment.php","title":{"rendered":"BMS Scholar Helps Lead Team Studying Worldwide Patented Innovations Available for Gene Therapy Treatment"},"content":{"rendered":"
\n
\"diagram
This illustration shows how a team of scientists from Purdue University and institutions around the world have come together to better understand the growing number of worldwide patented innovations available for gene therapy treatment. (Image provided)<\/figcaption><\/figure>\n<\/div>\n\n\n

The global gene therapy market is expected to reach $13 billion by 2024 as new treatment options target cancers and other diseases. Dr. Marxa Figueiredo, associate professor of basic medical sciences in the Purdue University College of Veterinary Medicine, has helped lead a team of scientists from Purdue and other research institutions around the world who came together to better understand the growing number of worldwide patented innovations available for gene therapy treatment.<\/p>\n\n\n\n

Dr. Figueiredo and her fellow team members specifically focus on nonviral methods, which use synthetic or natural compounds or physical forces to deliver materials generally less toxic than their viral counterparts into the therapy treatments. \u201cThe possibility of using nonviral vectors for gene therapy represents one of the most interesting and intriguing fields of gene therapy research,\u201d said Dr. Figueiredo, who works with the Purdue Research Foundation Office of Technology Commercialization to patent her technologies related to health. \u201cThis is an innovative method for identifying the technological routes used by universities and companies across the world and uncovering emerging trends for different gene therapy sectors.\u201d<\/p>\n\n\n\n

The scientists used big data, patent, and clinical data mining to identify technological trends for the gene therapy field. The team\u2019s work is presented in the February 7 edition of Nature Biotechnology<\/a>. They envision that their analysis will help guide future developments for gene therapy.<\/p>\n\n\n\n

The research project brought together investigators from across the globe in a joint effort to use new databases and methods to better understand the trends of the gene therapy field in respect to nonviral vectors. Dimas Covas, coordinator of the Center for Cell-based Therapy, affiliated with the University of S\u00e3o Paulo in Brazil, lent his extensive experience in cell therapy. Dr. Figueiredo, Aglaia Athanassiadou, and Virginia Pican\u00e7o-Castro contributed their extensive experience with nonviral vectors for gene therapy. Cristiano Pereira and Geciane Porto brought their expertise in economics and business administration to the analyses. Each contribution was fundamental to achieving a new way to identify technological trends in this field.<\/p>\n\n\n\n

\u201cThis work brought together investigators from very diverse\ndisciplines to create a different perspective on the gene therapy field,\u201d Dr. Figueiredo\nexplained. \u201cOur groups continue to work individually or in collaboration to\ngenerate and patent new vectors to help fill the needs of this re-emerging\nfield of nonviral gene therapy.\u201d<\/p>\n\n\n\n

The Purdue Research Foundation Office of Technology Commercialization<\/a> operates one of the most comprehensive technology transfer programs among leading research universities in the U.S. Services provided by the office support the economic development initiatives of Purdue University and benefit the university’s academic activities through commercializing, licensing and protecting Purdue intellectual property.\u00a0<\/p>\n\n\n\n

Click here to view\na complete news release about the research<\/a>. \n<\/p>\n","protected":false},"excerpt":{"rendered":"

The global gene therapy market is expected to reach $13 billion by 2024 as new treatment options target cancers and other diseases. Dr. Marxa Figueiredo, associate professor of basic medical sciences in the Purdue University College of Veterinary Medicine, has helped lead a team of scientists from Purdue and other research institutions around the world who came together to better understand the growing number of worldwide patented innovations available for gene therapy treatment.<\/p>\n","protected":false},"author":7,"featured_media":7634,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[36,41,29,11],"tags":[75,26,1557,56,538,150],"class_list":["post-7629","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","category-faculty-staff","category-our-people","category-research","tag-bms","tag-featured-story","tag-gene-therapy","tag-homepage","tag-marxa-figueiredo","tag-research"],"acf":[],"_links":{"self":[{"href":"https:\/\/vet.purdue.edu\/news\/wp-json\/wp\/v2\/posts\/7629","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vet.purdue.edu\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vet.purdue.edu\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vet.purdue.edu\/news\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/vet.purdue.edu\/news\/wp-json\/wp\/v2\/comments?post=7629"}],"version-history":[{"count":6,"href":"https:\/\/vet.purdue.edu\/news\/wp-json\/wp\/v2\/posts\/7629\/revisions"}],"predecessor-version":[{"id":33810,"href":"https:\/\/vet.purdue.edu\/news\/wp-json\/wp\/v2\/posts\/7629\/revisions\/33810"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vet.purdue.edu\/news\/wp-json\/wp\/v2\/media\/7634"}],"wp:attachment":[{"href":"https:\/\/vet.purdue.edu\/news\/wp-json\/wp\/v2\/media?parent=7629"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vet.purdue.edu\/news\/wp-json\/wp\/v2\/categories?post=7629"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vet.purdue.edu\/news\/wp-json\/wp\/v2\/tags?post=7629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}